World Library  
Flag as Inappropriate
Email this Article

Proteus vulgaris

Article Id: WHEBN0000594545
Reproduction Date:

Title: Proteus vulgaris  
Author: World Heritage Encyclopedia
Language: English
Subject: Proteus (bacterium), Enterobacteriaceae, Proteus OX19, P. vulgaris, Weil–Felix test
Collection: Enterobacteria
Publisher: World Heritage Encyclopedia

Proteus vulgaris

Proteus vulgaris
24-hour-old culture
Scientific classification
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacteriales
Family: Enterobacteriaceae
Genus: Proteus
Species: P. vulgaris
Binomial name
Proteus vulgaris
Hauser 1885

Proteus vulgaris is a rod-shaped, nitrate-reducing, indole+ and catalase-positive, hydrogen sulfide-producing, Gram-negative bacterium that inhabits the intestinal tracts of humans and animals. It can be found in soil, water, and fecal matter. It is grouped with the Enterobacteriaceae and is an opportunistic pathogen of humans. It is known to cause urinary tract infections and wound infections.

The term Proteus signifies changeability of form, as personified in the Homeric poems in Proteus, "the old man of the sea", who tends the sealflocks of Poseidon and has the gift of endless transformation. The first use of the term “Proteus” in bacteriological nomenclature was made by Hauser (1885), who described under this term three types of organisms which he isolated from putrefied meat. One of the three species Hauser identified was Proteus vulgaris, so this organism has a long history in microbiology.

Over the past two decades, the genus Proteus, and in particular P. vulgaris, has undergone a number of major taxonomic revisions. In 1982, P. vulgaris was separated into three biogroups on the basis of indole production. Biogroup one was indole negative and represented a new species, P. penneri, while biogroups two and three remained together as P. vulgaris.


  • Lab identification 1
  • Proteus infections 2
    • Etiology and epidemiology 2.1
    • Clinical expression 2.2
  • Treatments 3
  • References 4
  • See also 5

Lab identification

According to laboratory fermentation tests, P. vulgaris ferments glucose and amygdalin, but does not ferment mannitol or lactose. P. vulgaris also tests positive for the methyl red (mixed acid fermentation) test and is also an extremely motile organism.

When P. vulgaris is tested using the API 20E identification system[1] it produces positive results for sulfur reduction, urease production, tryptophan deaminase production, indole production, sometimes positive gelatinase activity, and saccharose fermentation, and negative results for the remainder of the tests on the testing strip.

It is referenced in the Analytical Profile Index using the nine-digit code: 047602157.

The optimal growing conditions of this organism is in a facultative anaerobic environment with an average temperature of about 40°C.

The Becton/Dickinson BBL Enterotube II system for identification of members of the family Enterobacteriaceae inoculated with P. vulgaris may yield the following results:

  • Positive for glucose fermentation (with gas production)
  • Negative for lysine and ornithine
  • Positive for hydrogen sulfide production and indole production
  • Negative for adonitol and lactose
  • Negative for arabinose, sorbitol and dulcitol
  • Positive for the phenylalanine test and the Harnstoff urea test

P. vulgaris can test positive or negative for citrate. All combine for a "Biocode ID of 31407" for use in the Interpretation Guide/Computer Coding and Identification System. P. vulgaris can also test urease negative in solid media (such as in Enterotube), but will be urease positive in liquid media. The CCIS code will still identify it with a negative urease test.

Proteus infections

Etiology and epidemiology

  • Nosocomial infections
  • P. mirabilis causes 90% of Proteus infections.
  • P. vulgaris and P. penneri are easily isolated from individuals in long-term care facilities and hospitals and from patients with underlying diseases or compromised immune systems.
  • Patients with recurrent infections, those with structural abnormalities of the urinary tract, those who have had urethral instrumentation, and those whose infections were acquired in the hospital have an increased frequency of infection caused by Proteus and other organisms (e.g., Klebsiella, Enterobacter, Pseudomonas, enterococci, and staphylococci).

Clinical expression

Enterobacteriaceae (of which Proteus is a member) and Pseudomonas species are the micro-organisms most commonly responsible for Gram-negative bacteremia and sepsis.

The presence of the sepsis syndrome associated with a urinary tract infection (UTI) should raise the possibility of urinary tract obstruction. This is especially true of patients who reside in long-term care facilities, who have long-term indwelling urethral catheters, or who have a known history of urethral anatomic abnormalities.

UTI obstruction

Urease production leads to precipitation of organic and inorganic compounds, which leads to struvite stone formation. Struvite stones are composed of a combination of magnesium ammonium phosphate (struvite) and calcium carbonate-apatite. Struvite stone formation can be sustained only when ammonia production is increased and the urine pH is elevated to decrease the solubility of phosphate. Both of these requirements can occur only when urine is infected with a urease-producing organism such as Proteus. Urease metabolizes urea into ammonia and carbon dioxide: urea 2 NH3 + CO2. The ammonia/ammonium buffer pair has a pK of 9.0, resulting in the combination of highly alkaline, ammonia-rich urine.

Symptoms attributable to struvite stones are uncommon. More often, women present with UTI, flank pain, or hematuria, and are found to have a persistently alkaline urine pH (>7.0).


Antibiotics to which P. vulgaris is known to be sensitive:

Sublactam or cefoperazone

Antibiotics should be introduced in much higher doses than "normal" when P. vulgaris has infected the sinus or respiratory tissues; for example, ciprofloxacin should be introduced at a level of at least 2000 mg per day orally in such a situation, rather than the "standard" 1000 mg per day.


  1. ^ "API Test Strips". Archived from the original on 7 November 2008. 

See also

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.